相关实验视频
Updated: May 16, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
7.9K
管理蛋过敏:对传统的过敏原避免方法和新兴的分级暴露策略进行系统审查
Aoife Gallagher1,2,3, Pamen Delgado Mainar4, Caoimhe Cronin1,3
1Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.
概括
儿童对蛋过敏的管理正在不断发展. 虽然严格避免是传统的,但新的,具有成本效益的方法,如逐步引入烤蛋等正在出现,以提高生活质量.
科学领域:
- 儿科过敏和免疫学
- 临床营养学 临床营养学
- 公共卫生 公共卫生
背景情况:
- 蛋过敏是一个越来越令人担忧的问题,特别是在儿童中.
- 传统的管理依赖于严格避免过敏原.
- 像口服免疫疗法这样的新疗法是资源密集的.
研究的目的:
- 为了比较严格避免与蛋过敏的新兴,具有成本效益的家庭管理策略.
- 审查有关蛋过敏管理的最新文献,重点关注分级暴露和避免过敏原.
主要方法:
- 医学数据库和灰色文献的系统审查 (2003-2023年).
- 选和评估了134个已识别的文章,其中28个被纳入分析.
- 专注于IgE介导的蛋过敏的干预措施,包括对变质/烤蛋的分级暴露.
主要成果:
- 观察到的一种转变是,除了避免外,还包括对变质/烤蛋的分级暴露.
- 大多数研究的重点是通过蛋暴露来对IgE介导的蛋过敏的管理.
- 避免过敏原仍然是基本的,但需要补充方法.
结论:
- 逐渐暴露于变质/烤蛋是一种有希望的,具有成本效益的替代方案,用于在家中管理蛋过敏.
- 补充策略对于优化结果,生活质量和饮食多样性至关重要.
- 经济因素和患者的福祉是蛋过敏管理策略的关键考虑因素.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
186
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
186
Allergic Reactions
27.2K
Overview
27.2K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Cross-reactivity
30.9K
Overview
30.9K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K

